The Virtual Biotech: A Multi-Agent AI Framework for Therapeutic Discovery and Development

杠杆(统计) 临床试验 数据科学 药物发现 计算机科学 药物开发 转化医学 精密医学 翻译科学 转化研究 制药工业 资源(消歧) 鉴定(生物学) 大数据 计算生物学 科学发现 药物重新定位 虚拟筛选 人类疾病 重新调整用途 知识管理 生物信息学
作者
Harrison G. Zhang,Peter Eckmann,Jiacheng Miao,Andrew B. Mahon,James Zou
出处
期刊: [Cold Spring Harbor Laboratory]
被引量:2
标识
DOI:10.64898/2026.02.23.707551
摘要

Abstract Drug discovery and development requires integrating diverse evidence across biological scales and data modalities. However, relevant data, tools, and expertise remain fragmented across teams and organizations, making integration difficult. To address these challenges, we introduce the Virtual Biotech, a coordinated team of AI agents that mirrors the structure of human therapeutic research organizations to support end-to-end computational discovery. The Virtual Biotech is led by a Chief Scientific Officer agent that receives scientific queries, delegates them to domain-specialized scientist agents, and integrates their outputs through data-driven reasoning. Scientist agents leverage complementary tools and knowledge sources spanning statistical genetics, functional genomics, pathways and interactions, chemoinformatics, disease biology, and clinical data. We showcase the Virtual Biotech across three translational applications. First, the agents autonomously annotated and analyzed outcomes from 55,984 clinical trials to identify genomic features of drug targets associated with trial success. More than 37,000 clinical-trialist agents curated structured trial outcomes and linked targets to multi-omic annotations, including cell-type-specific features derived by the agents from single-cell RNA-sequencing atlases. The agents discovered that drugs targeting cell-type-specific genes were 40% more likely to progress from Phase I to Phase II and 48% more likely to reach market (Phase IV), while exhibiting 32% lower adverse event rates. Second, the Virtual Biotech evaluated B7-H3 as a lung cancer target, integrating statistical genetics, single-cell, spatial, and clinicogenomic evidence to propose an antibody–drug conjugate strategy while identifying key liabilities and differentiation opportunities. Third, the platform analyzed a terminated ulcerative colitis trial targeting OSMR β to infer potential failure mechanisms and proposed biomarker-guided enrollment strategies to address precision-medicine gaps. Together, these results illustrate how the Virtual Biotech can enable more transparent, efficient, and comprehensive multi-scale therapeutic analyses, helping to accelerate early-stage drug discovery workflows while keeping human scientists in the loop.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhy1103完成签到 ,获得积分10
刚刚
1秒前
1秒前
余香的应助被追寻的沛白采纳,获得10
1秒前
情怀的应助被syy采纳,获得10
2秒前
3秒前
11111发布了新的文献求助10
3秒前
科研通AI6.4的应助被夏佳泽采纳,获得10
4秒前
L晨晨完成签到 ,获得积分10
4秒前
Firewoods发布了新的文献求助20
4秒前
bitter完成签到 ,获得积分10
5秒前
5秒前
6秒前
斯文败类的应助被Poseidon采纳,获得10
6秒前
6秒前
www完成签到,获得积分10
6秒前
6秒前
6秒前
6秒前
LWW发布了新的文献求助10
6秒前
7秒前
7秒前
好运附体完成签到,获得积分10
7秒前
舒服的飞丹完成签到 ,获得积分10
8秒前
走四方的应助被sunsuan采纳,获得10
8秒前
9秒前
Elaine发布了新的文献求助10
9秒前
10秒前
小台台发布了新的文献求助10
11秒前
11秒前
11秒前
尘归尘发布了新的文献求助10
11秒前
亦木发布了新的文献求助10
11秒前
皆辰发布了新的文献求助10
11秒前
拔丝香芋发布了新的文献求助10
12秒前
12秒前
theverve发布了新的文献求助30
12秒前
Debbie的应助被666采纳,获得10
13秒前
findpaper发布了新的文献求助30
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158017
求助须知:如何正确求助?哪些是违规求助? 9553900
关于积分的说明 21716555
捐赠科研通 7747340
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551639
邀请新用户注册赠送积分活动 2471005